On September 9th, from 16:00-17:15, our keynote speaker will be Prof. Dr. Stephan Herzig of the Helmholtz Diabetes Center in Munich, Germany. He will be joined by Dr. Dicky Struik of the University Medical Center Groningen.
Prof. Dr. Stephan Herzig (Helmholtz Diabetes Center Munich and the Institute for Diabetes and Cancer)
Professor Herzig’s paramount objective is to help people with diabetes. To achieve this, he holds key positions for bringing different research areas together and optimizing their orientation. He is director of the Helmholtz Diabetes Center and heads the Institute for Diabetes and Cancer. He is also speaker of the Helmholtz Graduate School Environmental Health (HELENA), coordinator of the Helmholtz program AMPro (Aging and Metabolic Programming), co-speaker of the Collaborative Research Center “Reactive Metabolites as a Cause of Diabetic Complications” and chairholder at Technische Universität München. “My personal research vision is to develop an effective prevention or treatment of diabetes using the findings of our basic research.”
Dr. Dicky Struik (University Medical Center Groningen)
Dicky Struik obtained his master’s degree in Biomedical Sciences at the University of Groningen. He finished his studies as an Erasmus student in the Department of Neuroscience at the University of Cagliari (Italy). After his studies, he continued to work as a research assistant in the Laboratory of Pediatrics at the University Medical Center Groningen. He started a Ph.D. project within the same department to understand the metabolic functions of fibroblast growth factor 1, an autocrine growth factor involved in adipose tissue remodeling. His postdoctoral research focuses on understanding how fibroblast growth factor receptor signaling pathways contribute to metabolic regulation and how pharmacological inhibition of this pathway in a oncological setting leads to unwanted metabolic toxicity.